The JAK2V617F mutation can occur in a hematopoietic stem cell that exhibits no proliferative advantage: a case of human allogeneic transplantation.

Van Pelt, Kristien; Nollet, Friedel; Selleslag, Dominik; Knoops, Laurent; Constantinescu, Stefan; Criel, Arnold; Billiet, Johan

doi:10.1182/blood-2008-04-154708

The JAK2V617F mutation can occur in a hematopoietic stem cell that exhibits no proliferative advantage: a case of human allogeneic transplantation.

Van Pelt, Kristien

;

Nollet, Friedel

;

Selleslag, Dominik

;

Knoops, Laurent

;

Billiet, Johan

;et.al.

(2008) Blood — Vol. 112, n° 3, p. 921-922 (2008)

Files

theJAK2V617Fmutationcanoccurin2008.pdf

Open Access
Adobe PDF
112.34 KB

Download

Details

Authors

Van Pelt, Kristien
Author
Nollet, Friedel
Author
Selleslag, Dominik
Author
Knoops, LaurentUCLouvain
Author
Constantinescu, StefanUCLouvain
Author
Billiet, Johan
Author

Affiliations

UCLouvainSSS/DDUV - Institut de Duve
UCLouvainMD/MIGE - Département de microbiologie, d'immunologie et de génétique
UCLouvain(SLuc) Service d'hématologie

Citations

APA
Chicago
FWB

Van Pelt, K., Nollet, F., Selleslag, D., Knoops, L., Constantinescu, S., Criel, A., & Billiet, J. (2008). The JAK2V617F mutation can occur in a hematopoietic stem cell that exhibits no proliferative advantage: a case of human allogeneic transplantation. Blood, 112(3), 921-922. https://doi.org/10.1182/blood-2008-04-154708 (Original work published 2008)